Novocure’s Optune will be tested alongside investigational Celgene drug marizomib.
Is digital the true solution to brain disorders?
Digital health round-up: Making a difference in brain disorders
Median overall survival improved from 15 months to 21 months when combined with chemotherapy.
Head patch device Optune improves brain cancer survival
Novocure’s Optune device shown to be safe and tolerable in recurrent ovarian cancer.
Electrical patch device shows promise against ovarian cancer